As the cost of prescription drugs generates increased controversy, Express Scripts (ESRX), the nation’s largest pharmacy benefit manager, will be removing still more medicines from its list of drugs covered by insurance, known as formularies.

In 2019, the PBM will exclude 242 medicines, compared with 196 this year, and the changes are forecast to save about $3.2 billion for its clients, such as health plans. The formulary covers approximately 25 million people, and about 0.2 percent of them are forecast to be affected by the changes.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • I am currently enrolled in tri care express scripts. Will I be notified if any of my drugs will be eliminated.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy